Literature DB >> 8023930

Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve.

M Kihara1, P J Zollman, I L Smithson, T D Lagerlund, P A Low.   

Abstract

Insulin administration can cause or worsen experimental and human diabetic neuropathy ("insulin neuritis"). In this study, we tested the hypothesis that insulin administration impairs tissue oxygenation. We infused insulin under nonhypoglycemic conditions and evaluated its effect on endoneurial oxygen tension, nerve blood flow, and the oxyhemoglobin dissociation curve of peripheral nerve in normal and diabetic rats. Intravenous insulin infusion resulted in a dose-dependent reduction in endoneurial oxygen tension in normal nerves (from 26% at 0.04 U/kg insulin to 55% at 32 U/kg). The nerves of rats with streptozotocin-induced diabetes were resistant, but with control of hyperglycemia this susceptibility to the endoneurial hypoxic effect of insulin returned. The reduction in endoneurial oxygen tension regressed with glycosylated hemoglobin (Y = 53.8-2.7X, where Y = %reduction in endoneurial oxygen tension and X = HbA1; r = 0.87; P = < 0.001). Diabetes or insulin administration resulted in only minimal and physiologically insignificant alterations in the oxygen dissociation curve and 2,3-diphosphoglycerate of sciatic nerve. Instead, insulin administration resulted in a reduction in nerve nutritive blood flow and an increase in arteriovenous shunt flow. When the latter was eliminated by the closure of arteriovenous shunts (infusion of 5-hydroxytryptamine), endoneurial oxygen reverted to normal. These findings indicate a deleterious vasoactive effect of insulin and may explain the development of insulin neuritis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023930     DOI: 10.1152/ajpendo.1994.266.6.E980

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

1.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

Review 2.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

3.  Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis).

Authors:  S Tesfaye; R Malik; N Harris; J J Jakubowski; C Mody; I G Rennie; J D Ward
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

4.  Structural abnormalities do not explain the early functional abnormalities in the peripheral nerves of the streptozotocin diabetic rat.

Authors:  D Walker; A Carrington; S A Cannan; D Sawicki; J Sredy; A J Boulton; R A Malik
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

5.  Murine model and mechanisms of treatment-induced painful diabetic neuropathy.

Authors:  Juliet M Nicodemus; Cynthia Enriquez; Alexandra Marquez; Carlos J Anaya; Corinne G Jolivalt
Journal:  Neuroscience       Date:  2017-05-03       Impact factor: 3.590

Review 6.  Treatment-Induced Neuropathy of Diabetes.

Authors:  Christopher H Gibbons
Journal:  Curr Diab Rep       Date:  2017-10-24       Impact factor: 4.810

7.  Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats.

Authors:  M A Cotter; A Love; M J Watt; N E Cameron; K C Dines
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

Review 8.  The spectrum of diabetic neuropathies.

Authors:  Jennifer A Tracy; P James B Dyck
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-02       Impact factor: 1.784

9.  Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.

Authors:  N E Cameron; M A Cotter; T C Hohman
Journal:  Diabetologia       Date:  1996-02       Impact factor: 10.122

10.  Neuroprotective effects of carvedilol in diabetic rats: prevention of defective peripheral nerve perfusion and conduction velocity.

Authors:  M A Cotter; N E Cameron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.